Aeterna Zentaris
AEZS
#10806
Rank
โ‚ฌ15.55 M
Marketcap
5,08ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Aeterna Zentaris (AEZS) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ1.49 Million

According to Aeterna Zentaris's latest financial reports the company's total debt is โ‚ฌ1.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Aeterna Zentaris - Total debt on balance sheet (from 2024 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ0.16 M17.38%
2021-12-31โ‚ฌ0.14 M-4.97%
2020-12-31โ‚ฌ0.14 M-81.44%
2019-12-31โ‚ฌ0.8 M
2018-12-31N/A
2011-12-31โ‚ฌ0.05 M
2008-12-31โ‚ฌ0.15 M-70.22%
2007-12-31โ‚ฌ0.53 M-50.78%
2006-12-31โ‚ฌ1.07 M-95.82%
2005-12-31โ‚ฌ25.81 M-44.89%
2004-12-31โ‚ฌ46.84 M96.99%
2003-12-31โ‚ฌ23.78 M-30.32%
2002-12-31โ‚ฌ34.13 M246.51%
2001-12-31โ‚ฌ9.85 M174.59%
2000-12-31โ‚ฌ3.58 M33.89%
1999-12-31โ‚ฌ2.67 M1123.04%
1998-12-31โ‚ฌ0.21 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
โ‚ฌ43.53 B 2,905,294.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ23.90 B 1,594,920.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ40.02 B 2,670,498.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ25.61 M 1,609.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚ฌ1.90 B 127,146.59%๐Ÿ‡บ๐Ÿ‡ธ USA